Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke

• Published in: Neurology Vol. 83; no. 21; p. 1954
• Main Authors: Thaler, David E, Ruthazer, Robin, Weimar, Christian, Serena, Joaquín, Mattle, Heinrich P, Nedeltchev, Krassen, Mono, Marie-Luise, Di Angelantonio, Emanuele, Elkind, Mitchell S V, Di Tullio, Marco R, Homma, Shunichi, Michel, Patrik, Meier, Bernhard, Furlan, Anthony J, Lutz, Jennifer S, Kent, David M
• Format: Journal Article
• Language: English
• Published: United States 18.11.2014
• Subjects: Adult; Aged; Choice Behavior; Cohort Studies; Databases, Factual - trends; Female; Fibrinolytic Agents - therapeutic use; Foramen Ovale, Patent - drug therapy; Foramen Ovale, Patent - epidemiology; Humans; Male; Middle Aged; Stroke - drug therapy; Stroke - epidemiology
• ISSN: 1526-632X
• DOI: 10.1212/WNL.0000000000001007

We examined the influence of clinical, radiologic, and echocardiographic characteristics on antithrombotic choice in patients with cryptogenic stroke (CS) and patent foramen ovale (PFO), hypothesizing that features suggestive of paradoxical embolism might lead to greater use of anticoagulation. The Risk of Paradoxical Embolism Study combined 12 databases to create the largest dataset of patients with CS and known PFO status. We used generalized linear mixed models with a random effect of component study to explore whether anticoagulation was preferentially selected based on the following: (1) younger age and absence of vascular risk factors, (2) "high-risk" echocardiographic features, and (3) neuroradiologic findings. A total of 1,132 patients with CS and PFO treated with anticoagulation or antiplatelets were included. Overall, 438 participants (39%) were treated with anticoagulation with a range (by database) of 22% to 54%. Treatment choice was not influenced by age or vascular risk factors. However, neuroradiologic findings (superficial or multiple infarcts) and high-risk echocardiographic features (large shunts, shunt at rest, and septal hypermobility) were predictors of anticoagulation use. Both antithrombotic regimens are widely used for secondary stroke prevention in patients with CS and PFO. Radiologic and echocardiographic features were strongly associated with treatment choice, whereas conventional vascular risk factors were not. Prior observational studies are likely to be biased by confounding by indication.